Tata Motors: Bumpy ride (Hep C Treatment)

Tata Motors: Bumpy ride
Business Standard India - Feb 09 10:43 AM
Tata Motors operating profit margin dropped by 1.04 basis points y-o-y to 12.28 per cent in the Q3 FY06. Operating profit increased by just 7.22 per cent to Rs 623.06 crore, though net sales have gone up by 16.31 per cent.Save to My Web

Catalyst Biosciences Raises $30 Million Series B Financing to Advance Therapeutic Proteases
[Press Release] PR Newswire via Yahoo! Finance - Feb 09 5:00 AM
Catalyst Biosciences, Inc., a privately held biotechnology company focused on engineering and developing novel therapeutic protease products, today announced it has raised $30 million in its Series B financing.Save to My Web

Notafa age-group athletics open
Sun Star - Feb 24 8:49 PM
ESCALANTE City play host Saturday to the revived monthly track and field age-group competitions of the Negros Occidental Track and Field Association. Competitions would be both in the elementary and secondary divisions.Save to My Web

Scientists Call For Hepatitis Treatment Of Young Injection Drug Users
Medical News Today - Feb 11 8:08 AM
In a recent study published in the journal Clinical Infectious Diseases, scientists from New York City, Baltimore, Seattle, and San Diego called for an immediate public health intervention to treat young injection drug users infected with the hepatitis C virus (HCV). In a careful review of over 400 individuals who tested positive for hepatitis C virus, 96% had conditions which would typically Save to My Web

ViroPharma Licenses Rights to Develop Novel Therapeutic for Treatment of Clostridium Difficile-Associated Disease
[Press Release] PR Newswire via Yahoo! Finance - Feb 27 8:15 AM
ViroPharma Incorporated today announced that the company has entered into a licensing agreement with Dr. Dale N. Gerding, Associate Chief of Staff for Research at the Hines VA Hospital, for the rights to develop non-toxigenic strains of C. difficile for the treatment and prevention of C. difficile-associated disease .Save to My Web

Transition Therapeutics Announces Second Quarter Fiscal 2006 Financial Results
[Press Release] CNW Group via Yahoo! Finance - Feb 14 5:33 AM
Transition Therapeutics Inc. , a biopharmaceutical company focused on developing therapeutics for disease indications with large markets, today announced its financial results for the quarter ended December 31, 2005.Save to My Web